Borisun Tablet 0.3mg (Voglibose)

Adult dosage

Since efficacy and tolerability vary among patients, the physician must determine the dose according to each patient's condition. The usual administration is as follows. The usual adult dose is 0.2mg of voglibose per administration, taken orally 3 times daily before each meal. If the effect is insufficient, the dose per administration may be increased to 0.3mg while carefully monitoring the patient's progress.

This medication should not be used in patients with severe ketoacidosis or diabetic coma. It should also be avoided in patients with severe infections or those undergoing surgery, as well as in patients with severe trauma. Patients allergic to this drug's ingredients should not use it. This drug contains lactose, so it should not be administered to patients with galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. Patients with poor digestive function or chronic intestinal diseases should use this medication carefully, and extra caution is needed if excessive intestinal gas worsens symptoms. Patients with severely impaired liver or kidney function or the elderly should also use this medication with caution. When used with other hypoglycemics, there is a risk of hypoglycemia, so it is essential to start with a low dose and monitor closely. This medication can cause hypoglycemia, so if symptoms of hypoglycemia occur, glucose should be consumed instead of sugar. Symptoms such as abdominal bloating, increased flatulence, and signs of liver dysfunction may occur, so if these symptoms arise, immediate consultation with a physician is necessary. Patients with liver cirrhosis should monitor their bowel movements closely, as constipation may lead to increased ammonia levels and cognitive dysfunction. This medication is only to be used for patients diagnosed with diabetes, and for those who are managed solely by diet and exercise, it should only be considered when blood sugar levels exceed a certain threshold. During treatment, regular blood sugar checks should be conducted to continually assess the drug's efficacy and necessity. Women who are pregnant or may become pregnant should use this medication cautiously, as its safety has not been established, and nursing mothers should also avoid it if possible. Safety has not been established for children, so there is no experience using it in this population. The elderly may have reduced bodily functions, so they should start with a low dose and carefully monitor blood sugar and gastrointestinal symptoms.

• Hypoglycemia
• abdominal distension
• increased flatulence
• symptoms of intestinal obstruction
• acute hepatitis
• elevated AST
• elevated ALT
• severe liver dysfunction
• jaundice
• altered consciousness

This medication should be stored in a tightly sealed container to prevent air ingress, at a temperature between 1 degrees and 30 degrees Celsius. Proper storage can help maintain the drug's efficacy over a longer period.

Appearance

White or pale yellow round tablet

Package unit

30 tablets/bottle, 300 tablets/bottle